ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,116.17
0.32%
Dow Jones
38,386.09
0.38%
US Dollar vs MXN
16.9883
-0.15%
Brent Oil
87.375
0.10%
Bitcoin
61,642.35
-3.44%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Quanterix Corporation (QTRX)

  7. Quanterix Corporation (QTRX) Noticias

QTRX Quanterix Corporation

15.58
0.00 (0.00%)
Pre Mercado
Última actualización: 03:09:57
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Quanterix Corporation QTRX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 15.58 03:09:57
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
15.58
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/4/202415:00BWQuanterix To Report First Quarter 2024 Financial Results
21/3/202416:30BWQuanterix Outlines Partner Path With Labs to Expedite..
04/3/202416:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/3/202415:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202408:00BWQuanterix Granted Breakthrough Device Designation from U.S...
29/2/202415:58EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202415:00BWQuanterix Releases Operating Results for Fourth Quarter and..
26/2/202417:58BWQuanterix Reschedules Q4 and Full Year 2023 Earnings..
26/2/202408:00BWQuanterix Announces First Collaborations with Five Health..
23/2/202415:30BWQuanterix to Present at Cowen’s 44th Annual Health Care..
16/2/202415:00BWQuanterix Fourth Quarter Earnings and Full Year 2023..
15/2/202416:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202415:57EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202415:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202415:05EDGAR2Form 8-K - Current report
04/1/202415:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202415:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202416:21EDGAR2Form 144 - Report of proposed sale of securities
12/12/202315:00BWQuanterix to Present at 42nd Annual J.P. Morgan Healthcare..
01/12/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202315:00BWQuanterix To Participate at The Canaccord Genuity MedTech,..
13/11/202306:00GLOBESotera Health Appoints Karen Flynn to Board of Directors
06/11/202316:56BWQuanterix Releases Operating Results for Third Quarter 2023
06/11/202316:03EDGAR2Form 8-K - Current report
06/11/202315:50BWQuanterix Releases Operating Results for Third Quarter 202
01/11/202308:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202315:00BWQuanterix to Report Third Quarter 2023 Financial Results on..
24/10/202315:30BWQuanterix Launches High Accuracy p-Tau 217 Blood Biomarker..
23/10/202319:30BWQuanterix Announces New Agreement to Advance Blood Based..
02/10/202316:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202316:00BWQuanterix CEO to Speak at Goldman Sachs Alzheimer’s Disease..
06/9/202315:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202307:00BWQuanterix to Participate at the Morgan Stanley 21st Annual..
22/8/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202315:02EDGAR2Form 8-K - Current report
21/8/202315:30BWWilliam P. Donnelly Appointed to Quanterix’s Board of..
09/8/202307:52EDGAR2Form 8-K - Current report
09/8/202307:30BWQuanterix Appoints Vandana Sriram as Chief Financial Officer
08/8/202309:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202316:21EDGAR2Form 8-K - Current report
07/8/202316:13BWQuanterix Releases Operating Results for Second Quarter 2023
03/8/202307:00BWQuanterix to Present at Canaccord Genuity 43rd Annual Growth..
02/8/202315:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202307:00BWQuanterix’s Simoa® Technology Powers Large, International..
20/7/202307:00BWQuanterix to Report Second Quarter 2023 Financial Results on..
06/7/202316:37BWQuanterix Launches LucentAD Biomarker Blood Test to Aid..
05/7/202315:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202315:00BWQuanterix to Participate in Fireside Chat at Goldman Sachs..

Su Consulta Reciente

NASDAQ
QTRX
Quanterix
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados